This past year, the clinical trials landscape continued to shift and adapt to promising trends—including mobile technology, real-world data, and patient engagement—that can help us build a stronger clinical trials system.
Outsourcing models examined, market shifts scrutinized, and trial tribulations analyzed – take a look back at some of the top reports published in 2017.
Marken has acquired Touchdown International Ltd, a privately held specialty logistics company in Taiwan – a “key market” for pharma production and clinical trials.
The combined offering leverages Elligo’s infrastructure and services to enable Allscripts physicians to participate as study investigators in contract research organization-managed (CRO) clinical trials.
Worldwide Clinical Trials has planned its rollout and risk mitigation strategy as it implements Medidata’s Payments Cloud to automate site payments, says CFO.
Patient-operated mobile technology will be demanded on all clinical trials, says mProve, as the industry undergoes an evolution and embraces digital health solutions.
The CRO market in Asia has “massive implications” as it continues to emerge as a preferred destination for clinical trials – a global market expected to reach $57bn by 2020.
With a tax incentive program making clinical trials up to 60% more cost-effective, Australia is a “gateway” to larger studies throughout Asia, says CRO.
The Society for Clinical Research Sites recently awarded QuintilesIMS with the 2016 Eagle Award, which recognizes contract research organizations (CRO) and sponsors focusing on site relationships.
The Obama administration recently finalized new rules that require researchers to make trial data public as the industry grapples with evolving data standards and looks to uphold its pledge to clinical trial participants.
Marken’s Moscow-based depot has been granted a new pharmaceutical license from the Russian Federation, further extending the company’s capabilities in the area.
As clinical trials “continue to shift to emerging markets,” the translation company Welocalize has acquired Global Language Solutions (GLS) to further support its clients’ linguistic validation processes.
Covance has rolled out a consulting designed to help trial sponsors check that mobile apps they plan to use in clinical research meet with regulatory guidelines.
With 320m monthly active users, Twitter could potentially serve as a new, unexploited resource to stimulate interest and enrollment in clinical trials.
The pharma industry has traditionally been slow to adopt mobile technology, but as new innovations emerge the process for conducting clinical trials could transform.
Currently, more than 85% of trial sites are paid using manual or in-house process, but as the need for CROs increases, so does the need for automated payments, says Clinverse's CEO.
A professor who conducted fast-track trials during last year’s Ebola outbreak says next time such trials must be part of humanitarian response… because there will be a next time.
The Coalition for Clinical Trials Awareness (CCTA) has called for a federally-supported public health campaign to make people more aware of drug research and the value of participating in studies.
The number of clinical trials given the green light in Russia has increased 13% in the third quarter of the year, which could be thanks in part to a reduction in red tape.
Science 37 has raised $6.5m (€5.7m) from Lux Capital and dRx Capital, the fund set up by Novartis and Qualcomm, to advance its virtual clinical trial service business.
Results from all UK-funded vaccine trials will be made public according to Prime Minister David Cameron, who suggested failure to share data exacerbated the Ebola outbreak.
The proportion of pediatric trials of all clinical trials in the EU continues to increase since the integration of a Pediatric regulation in 2007, despite a decrease in the number of clinical trials overall since then, according to a new report from the...
The Ministry of Health of the Russian Federation approved 151 total clinical studies in Q1 of 2015, which is 11% less than the same quarter last year, though by comparison, it’s still 10 times more than India has approved in the same amount of time.
Publishing summary clinical trial results poses no threat to patient privacy according to the WHO, which says enforcing transparency laws and incentivising sponsors is key to making sure data from all trials is reported.
Fluctuations in regulations over the past few years have reduced the number of clinical trials run on the subcontinent, but now governing bodies are looking at new ways to attract trials and further control the industry.
As part of a major transparency effort, the NIH (National Institutes of Health) and FDA are proposing to require the release of summary results of clinical trials for products that are unapproved or unlicensed.
Medidata has completed a method development project conducted in partnership with GlaxoSmithKline to evaluate the impact of combining mobile health (mHealth) devices with cloud-based technologies in a clinical trial.
A UK writer has described how his mission to start a trial for a therapeutic virus against his friend’s cancer has led to a new model of research funding which bypasses sponsors and CROs.
CRO Pharmaceutical Product Development (PPD) announced today that it has acquired for an undisclosed sum RCT Logic’s exclusive license from Massachusetts General Hospital (MGH) for the portfolio of patents related to its sequential parallel comparison...
In order to ensure uniformity on the state and federal levels, India’s CDSCO (Central Drugs Standard Control Organization) has released seven procedural criteria for state drug inspectors to abide by.
The Association of Clinical Research Organizations (ACRO) offered a number of recommendations to the US House Energy and Commerce Committee’s “21st Century Cures” initiative last week as part of an effort to keep the US research industry competitive globally.
